TOMI Environmental Solutions, Inc. Announces FDA Broadens Permitted Use of Hydrogen Peroxide; Ruling Significantly Expands Potential Application of SteraMist iHP in Food Industry
FREDERICK, Md., Sept. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that the U.S. Food and Drug Administration (FDA) has broadened the permitted use of hydrogen peroxide as a secondary direct food additive. This change, outlined in the final rule published on September 3, 2025 (90 FR 42535), amends 21 CFR §173.356. With SteraMist formulated primarily from food-grade hydrogen peroxide and deionized water, TOMI is now well-positioned to pursue growth opportunities in the food industry.
The new FDA rule permits the use of food-grade hydrogen peroxide that complies with Food Chemicals Codex (FCC), 14th Edition specifications, in food production, provided that any trace residues are completely removed before the food reaches consumers.
TOMI's SteraMist Binary Ionization Technology (BIT) Solution uses a low concentration of hydrogen peroxide combined with deionized water, both of which are recognized as safe for food use. The SteraMist application method ensures no detectable residues remain on the final food product, aligning with the new FDA requirements. The SteraMist iHP formulation also contains a small, non-residual proprietary component that is not expected to pose any safety concerns under the conditions of use.
"We are very pleased with the FDA's new rule, as it formally recognizes the potential for hydrogen peroxide to be used more broadly in the food industry, further validating the science behind our SteraMist iHP technology and opening up a significant market opportunity for TOMI Environmental," said Elissa J. Shane, COO of TOMI Environmental Solutions. "A study published in the Journal of Food Protection supports our findings, demonstrating that hydrogen peroxide residues on fresh produce treated with ionized hydrogen peroxide technology decomposed rapidly and did not appear to pose a safety concern after one day of storage. The FDA's updated regulation, coupled with the supporting scientific data, provides a clear path for food processors to adopt advanced, residue-free technologies like SteraMist iHP to enhance food safety and protect consumers. This opens verticals in food safety, food transportation, food storage, food packaging, direct spraying of food pre- and post-harvest, outbreak control, and preventive pathogen reduction, along with increasing the longevity of all food types.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to the impact of FDA ruling and TOMI’s products to serve food sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
